Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 11 years
- Director since
- 2023
11 years of board service in total across 3 boards, counting each seat separately. Longest: Enliven Therapeutics Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Oric Pharmaceuticals Inc. June 12, 202475.4%
-
Enliven Therapeutics Inc. June 23, 202398.8%
-
PMV Pharmaceuticals Inc. June 8, 202381.2%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 1, 2026 | Oric Pharmaceuticals Inc. | Option exercise | +3,500 | $1.60 | $5,600 |
| Oct 1, 2026 | Oric Pharmaceuticals Inc. | Open-market sale | −3,500 | $12.91 | $45,199 |
| Oct 1, 2026 | Oric Pharmaceuticals Inc. | Open-market sale | −3,200 | $12.91 | $41,325 |
| Jul 24, 2026 | Oric Pharmaceuticals Inc. | Option exercise | +3,500 | $1.60 | $5,600 |
| Jul 24, 2026 | Oric Pharmaceuticals Inc. | Open-market sale | −7,000 | $12.02 | $84,140 |
| Jul 24, 2026 | Oric Pharmaceuticals Inc. | Open-market sale | −6,100 | $12.02 | $73,322 |
| Jul 6, 2026 | Oric Pharmaceuticals Inc. | Open-market sale | −300 | $12.00 | $3,600 |
| Feb 17, 2026 | Enliven Therapeutics Inc. | Open-market sale | −1,230 | $26.18 | $32,201 |
| Jan 20, 2026 | Enliven Therapeutics Inc. | Open-market sale | −512 | $26.46 | $13,548 |
| Jan 20, 2026 | Enliven Therapeutics Inc. | Open-market sale | −718 | $26.96 | $19,357 |
| Jan 16, 2026 | Oric Pharmaceuticals Inc. | Open-market sale | −3,500 | $12.00 | $42,000 |
| Jan 16, 2026 | Oric Pharmaceuticals Inc. | Open-market sale | −3,200 | $12.00 | $38,400 |
| Jan 9, 2026 | Enliven Therapeutics Inc. | Open-market sale | −4,285 | $25.00 | $107,125 |
| Jan 8, 2026 | Enliven Therapeutics Inc. | Open-market sale | −1,620 | $25.00 | $40,500 |
| Jan 8, 2026 | Enliven Therapeutics Inc. | Open-market sale | −8,015 | $25.04 | $200,696 |
Questions about Richard A. Heyman
What boards is Richard A. Heyman on?
Richard A. Heyman sits on the boards of Enliven Therapeutics Inc., Oric Pharmaceuticals Inc. and PMV Pharmaceuticals Inc.
How long has Richard A. Heyman served on boards?
Our records show at least 11 years of board service across 3 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.